Verified Nov 2026
Other
·
Exton, Pennsylvania
·
Since 1923
West Pharmaceutical Services is a manufacturer of containment and delivery systems for injectable medicines, headquartered in Exton, Pennsylvania, and founded in 1923. The company employs roughly 10,000 to 50,000 people and is publicly traded on the New York Stock Exchange under the ticker WST, with reported revenue of about $3.1 billion. It serves pharmaceutical, biotechnology, medical, and automotive or electric-vehicle industries. In January 2026 it agreed to sell the manufacturing and supply rights for its SmartDose 3.5mL on-body delivery system to AbbVie.
West Pharmaceutical Services at a glance
Revenue
3.1B
Employees
10,000-50,000
Founded
1923
Headquarters
Exton, Pennsylvania
Ownership
Publicly traded (NASDAQ: WST)
Certifications
ISO 13485 · ISO 9001
Import activity
1410
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
1410
Named foreign suppliers
50
Top origins
Singapore · Belgium · Japan · Israel
Shared foreign counterparties do not establish that these companies buy from West Pharmaceutical Services.
What this tells a buyer
No customs trade data is available for the company, so its trade footprint cannot be characterized; its most recent reported development is a January 2026 agreement with AbbVie covering manufacturing and supply rights for its SmartDose 3.5mL on-body delivery system.
The company lists ISO 13485 and ISO 9001 certifications and reports producing components from rubber, plastic, aluminum, and glass, with facilities in Dublin, Ireland, Tempe, Arizona, and Stolberg, Germany.
West is included in the S&P 500 index and reports serving pharmaceutical and biotechnology firms worldwide, with an expansion of its Dublin facility announced in March 2026 to support high-volume injectable therapies.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
103 years in operation (founded 1923).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
West Pharmaceutical Services is a manufacturer of containment and delivery systems for injectable medicines, headquartered in Exton, Pennsylvania, and founded in 1923. The company employs roughly 10,000 to 50,000 people and is publicly traded on the New York Stock Exchange under the ticker WST, with reported revenue of about $3.1 billion. It serves pharmaceutical, biotechnology, medical, and automotive or electric-vehicle industries. In January 2026 it agreed to sell the manufacturing and supply rights for its SmartDose 3.5mL on-body delivery system to AbbVie.
At a glance
Attribute | Detail |
|---|---|
Founded | 1923 |
Headquarters | Exton, Pennsylvania |
Employees | 10,000-50,000 |
Revenue | 3.1B |
Ownership | Publicly traded (NASDAQ: WST) |
Certifications | ISO 13485 · ISO 9001 |
What West Pharmaceutical Services makes
The company lists ISO 13485 and ISO 9001 certifications and reports producing components from rubber, plastic, aluminum, and glass, with facilities in Dublin, Ireland, Tempe, Arizona, and Stolberg, Germany.
Products and capabilities described on the company's own site include Mold, Rubber, Plastic, Aluminum, Glass (source: westpharma.com).
Certifications
West Pharmaceutical Services is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — westpharma.com
ISO 9001 — westpharma.com
Trade and customs footprint
No customs trade data is available for the company, so its trade footprint cannot be characterized; its most recent reported development is a January 2026 agreement with AbbVie covering manufacturing and supply rights for its SmartDose 3.5mL on-body delivery system. US customs bill-of-lading records list 1410 inbound shipments across 50 foreign suppliers, with top origins including Singapore · Belgium · Japan · Israel.
Latest developments
2026-10-29 — West Reports Third-Quarter 2026 Results - Thu, 10/29/2026 - 06:00 (westpharma.com)
2026-04-09 — West Pharmaceutical Services Highlights Key Capital Projects in Contract Mfg Business - DCAT Value Chain Insights (dcatvci.org)
2026-03-31 — West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity - Tue, 03/31/2026 - 11:46 (westpharma.com)
2026-01-12 — West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie - Mon, 01/12/2026 - 06:00 (westpharma.com)
2026-01-08 — West Expands into Indiana, Creating Jobs and Strengthening the Midwest Pharmaceutical Supply Chain (hancockedc.com)
2026-01-08 — Pharmaceutical company planning to employ 300 workers in Greenfield – Inside INdiana Business (insideindianabusiness.com)
Facilities
West Pharmaceutical Services is headquartered in Exton, Pennsylvania. Public sources also reference these locations:
Dublin, Ireland — dcatvci.org
Tempe, Arizona — abbvie.com
Stolberg, Germany — westpharma.com
Company details
West is included in the S&P 500 index and reports serving pharmaceutical and biotechnology firms worldwide, with an expansion of its Dublin facility announced in March 2026 to support high-volume injectable therapies. West Pharmaceutical Services was founded in 1923, has an estimated 10,000-50,000 employees, and is headquartered in Exton, Pennsylvania. On the LightSource stability read it is rated "Established & strong": 103 years in operation (founded 1923). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does West Pharmaceutical Services do?
West Pharmaceutical Services is a manufacturer of containment and delivery systems for injectable medicines, headquartered in Exton, Pennsylvania, and founded in 1923. The company employs roughly 10,000 to 50,000 people and is publicly traded on the New York Stock Exchange under the ticker WST, with reported revenue of about $3.1 billion. It serves pharmaceutical, biotechnology, medical, and automotive or electric-vehicle industries. In January 2026 it agreed to sell the manufacturing and supply rights for its SmartDose 3.5mL on-body delivery system to AbbVie.
Where is West Pharmaceutical Services headquartered?
West Pharmaceutical Services is headquartered in Exton, Pennsylvania (530 Herman O. West Drive, Exton, Pennsylvania, 19341).
When was West Pharmaceutical Services founded?
West Pharmaceutical Services was founded in 1923.
How big is West Pharmaceutical Services?
West Pharmaceutical Services has an estimated 10,000-50,000 employees, with revenue in the 3.1B range.
Is West Pharmaceutical Services publicly traded?
Publicly traded (NASDAQ: WST). Public financial figures are drawn from its filings.
What certifications does West Pharmaceutical Services hold?
West Pharmaceutical Services lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.